GWPH News and Press, GW Pharmaceuticals Plc From 07/10/20

This week in the cannabis sector, we saw news out of Aurora Cannabis (ACB) and GW Pharmaceuticals (GWPH), and Aphria (APHA) continues its slide. This has been a volatile week for the cannabis sector as COVID infections continue to hit records in the United States. The MG Alternative Harv...

Analyst affirms Buy rating in G.W. Pharmaceuticals (GWPH) stock. Since hitting its low in March, G.W. Pharmaceuticals ( GWPH ) stock has climbed to about $130 per share. The company, which has a $4 billion valuation, generated close to $300 million in sales for its epilepsy drug Epidio...

Many marijuana stocks performed miserably in the first half of 2020. There were multiple factors at play behind the generally dismal returns, with the COVID-19 pandemic weighing on shares of quite a few companies in the cannabis industry. However, there were still some marijuana stocks that del...

Investors in the emerging psychedelic sector may need to brush up on the steps taken by the cannabis industry across the capital markets. While the psychedelic industry may not have a direct path to profitability like cannabis did in the lead-up to legalization, advocates have been quick...

How Has 2020 Helped to Push These Pot Stocks Upward so Far? 2020 has already been a pivotal year for marijuana stocks . With many of the leading pot stocks to watch posting big losses, in the beginning, we have now seen that sentiment turn around. In the past three to four months, it has been...

For years, there wasn't a hotter investment opportunity on Wall Street than marijuana stocks. Until the end of the first quarter of 2019, you could have thrown a dart at a list of publicly traded pot stocks and likely come out a significant winner. But all of that changed in April 2019. Over th...

This week in the cannabis sector, we saw news out of Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), and GW Pharmaceuticals (GWPH)   This week was another disappointing week for cannabis stocks as their momentum continued to fade, despite the optimism in the bro...

The following slide deck was published by GW Pharmaceuticals plc in conjunction with this Read more ...

GW Pharmaceuticals plc (NASDAQ:GWPH) has pushed the legalization of cannabis ahead with its work on the drug Epidiolex. Now the company is making its plans for its other cannabis drug Sativex known and it’s impressive and hopeful. The company is announcing its plans for its pipe...

GW Pharmaceuticals (NASDAQ: GWPH ) announces strategy for bringing its pipeline product nabiximols to the U.S. market. More news on: GW Pharmaceuticals plc, Healthcare stocks news, Read more ...